查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589533

直接面對消費者的基因檢測市場：按類型、管道和功能分類 - 2025-2030 年全球預測

Direct-to-Consumer Genetic Testing Market by Type (Mitochondrial DNA Testing, Single Nucleotide Polymorphism Testing, Y Chromosome Testing), Channel (Offline, Online), Function - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年直接面對消費者的基因檢測市場價值為20.2億美元，預計2024年將達到23.6億美元，複合年成長率為17.21%，到2030年將達到61.5億美元。

直接面對消費者 (DTC) 的基因檢測使消費者無需直接參與醫療保健專業人員即可獲得基因檢測服務，使個人能夠直接了解自己的血統、健康風險和傾向。消費者對個人化健康資訊和主動健康管理的興趣日益成長，推動了對此類服務的需求。這些測試可應用於多個領域，包括譜系研究、遺傳疾病易感性篩檢以及個人化飲食和健身計劃。主要最終使用者是注重健康的個人、系譜和注重健康、尋求對其遺傳資訊擁有更大自主權的企業。基因研究的進步、定序技術成本的降低以及消費者意識和對個人化醫療解決方案的需求的提高對市場成長產生了重大影響。然而，該市場也面臨一些障礙，例如對資料隱私的擔憂、複雜的監管環境以及在沒有專家指導的情況下遺傳資料可能被誤解的可能性。儘管存在這些挑戰，但仍有很大的機會來擴大有關使用遺傳資訊的消費者教育、制定強力的資料隱私措施以及整合人工智慧以增強資料解釋。公司可以透過投資透明的資料保護通訊協定、與醫療保健專業人員合作提供客戶指導以及透過全面的教育舉措來提高客戶參與來利用這些機會。研究和創新應專注於提高測試準確性、擴大健康狀況的覆蓋範圍以及開發方便用戶使用的平台，將遺傳見解整合到可行的醫療保健計劃中。 DTC 基因檢測市場的本質是動態的和消費者主導的，其特點是技術的快速採用和解決現有限制和市場需求的巨大創新空間。優先考慮道德因素並專注於提供可靠且可行的見解的公司將處於有利地位，能夠在這個不斷發展的市場中實現持續成長。

主要市場統計
基準年[2023] 20.2億美元
預測年份 [2024] 23.6億美元
預測年份 [2030] 61.5億美元
複合年成長率（%） 17.21%

市場動態：揭示快速發展的直接面對消費者的基因檢測市場的關鍵市場洞察

供需的動態交互作用正在改變直接面對消費者的基因檢測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 隨著消費者尋求對自己的醫療保健有更多控制權，模式轉移
    • 提高對基因組檢測和遺傳疾病風險的認知
    • 高齡化社會的進展與慢性病的蔓延
    • 對評估血統和祖先的好奇心不斷增加
  • 市場限制因素
    • 相關科學、技術和臨床問題
    • 第一修正案關於廣告中的誠實、忠於事實和真相的問題
  • 市場機會
    • 用於當前和未來基因診斷的次世代定序儀和生物晶片
    • 開發滿足客戶需求的線上應用程式
  • 市場挑戰
    • 測試結果解釋的複雜性
    • 醫生缺乏足夠的遺傳學知識

波特五力：駕馭直接面對消費者的基因檢測市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解直接面對消費者的基因檢測市場的外部影響

外部宏觀環境因素在塑造直接面對消費者的基因檢測市場表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解直接面對消費者的基因檢測市場的競爭格局

對直接面對消費者的基因檢測市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣供應商在直接面對消費者的基因檢測市場的績效評估

FPNV定位矩陣是評估直接面對消費者的基因檢測市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，為直接面對消費者的基因檢測市場制定成功之路

對於旨在加強其在全球市場的影響力的公司來說，對直接面對消費者的基因檢測市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 模式轉移：消費者希望更好地控制他們的醫療保健管理
      • 提高對基因組檢測和遺傳疾病風險的認知
      • 隨著人口不斷老化，慢性病的發生率也增加。
      • 人們對評估血統和血統的興趣日益濃厚
    • 抑制因素
      • 相關科學、技術和臨床問題
      • 第一修正案關於廣告中的誠實、事實忠實和真相的問題
    • 機會
      • 用於當前和未來基因診斷的次世代定序和生物晶片
      • 開發滿足客戶需求的線上應用程式
    • 任務
      • 解釋測試結果的複雜性
      • 醫生缺乏足夠的遺傳學知識
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 直接面對消費者的基因檢測市場：依類型

  • 粒線體DNA測試
  • 單核苷酸多態性檢測
  • Y染色體測試

第7章 直接面對消費者的基因檢測市場：按管道

  • 離線
  • 線上

第8章 直接面對消費者的基因檢測市場：依功能分類

  • 血統和種族
  • 癌症篩檢
    • 遺傳性癌症
      • 血癌
      • 乳癌
      • 卵巢癌
    • 散發性癌症
  • 遺傳疾病帶因者狀況
  • 新生兒篩檢
  • 特徵
  • 健康

第9章 美洲直接面對消費者的基因檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區直接面對消費者的基因檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲直接面對消費者的基因檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Ancestry.com LLC
  • Dante Labs Inc.
  • EasyDNA
  • FamilyTreeDNA by Gene, Ltd.
  • Genesis Healthcare Co.
  • Helix OpCo, LLC
  • Karmagenes SA
  • Living DNA Ltd.
  • Mapmygenome
  • Merck KGaA
  • MyHeritage Ltd.
  • Positive Biosciences, Ltd.
  • Shuwen Biotech Co. Ltd.
  • Vitagene, Inc.
  • Xcode Life
Product Code: MRR-4312A385A4B9

The Direct-to-Consumer Genetic Testing Market was valued at USD 2.02 billion in 2023, expected to reach USD 2.36 billion in 2024, and is projected to grow at a CAGR of 17.21%, to USD 6.15 billion by 2030.

Direct-to-consumer (DTC) genetic testing allows consumers to access genetic testing services without the direct involvement of healthcare professionals, enabling individuals to obtain insights into ancestry, health risks, and predispositions directly. The necessity for such services is driven by the increasing consumer interest in personalized health information and proactive health management. These tests hold application across several domains, including genealogical research, predisposition screening for hereditary diseases, and personalized diet and fitness planning. The primary end-users are health-conscious individuals seeking greater autonomy over their genetic information, genealogists, and wellness-oriented companies. Market growth is significantly influenced by advancements in genetic research, cost reductions in sequencing technologies, and rising consumer awareness and demand for personalized healthcare solutions. However, the market also faces hurdles such as concerns surrounding data privacy, regulatory landscape complexities, and the potential for misinterpretation of genetic data without professional guidance. Despite these challenges, there lies a substantial opportunity in expanding consumer education on genetic information usage, developing robust data privacy measures, and integrating AI for enhanced data interpretation. Companies can capitalize on these opportunities by investing in transparent data protection protocols, collaborating with healthcare professionals for customer guidance, and enhancing customer engagement through comprehensive education initiatives. Research and innovation should focus on advancing test accuracy, expanding the scope of health conditions covered, and developing user-friendly platforms that integrate genetic insights into actionable healthcare plans. The nature of the DTC genetic testing market is dynamic and consumer-driven, characterized by rapid technological adoption and a significant scope for innovation to address existing limitations and market demands. Companies that prioritize ethical considerations and focus on delivering reliable and actionable insights will be well-positioned for sustained growth in this evolving market.

KEY MARKET STATISTICS
Base Year [2023] USD 2.02 billion
Estimated Year [2024] USD 2.36 billion
Forecast Year [2030] USD 6.15 billion
CAGR (%) 17.21%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Direct-to-Consumer Genetic Testing Market

The Direct-to-Consumer Genetic Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Paradigm shift among consumers seeking greater control over their own healthcare
    • Rising awareness about genome testing and risk of genetic diseases
    • High aging population coupled with growing prevalence of chronic disorders
    • Increased inquisitiveness about the assessment of lineage and ancestry
  • Market Restraints
    • Related scientific, technical, and clinical issues
    • First amendment issues of honesty, fidelity to facts, and truth-in-advertising
  • Market Opportunities
    • Next-generation sequencing and bio-chip for present and future genetic diagnosis
    • Development of online applications to serve customer needs
  • Market Challenges
    • Complexity of test result interpretation
    • Lack of adequate physician knowledge about genetics

Porter's Five Forces: A Strategic Tool for Navigating the Direct-to-Consumer Genetic Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Direct-to-Consumer Genetic Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Direct-to-Consumer Genetic Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Direct-to-Consumer Genetic Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Direct-to-Consumer Genetic Testing Market

A detailed market share analysis in the Direct-to-Consumer Genetic Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Direct-to-Consumer Genetic Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Direct-to-Consumer Genetic Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Direct-to-Consumer Genetic Testing Market

A strategic analysis of the Direct-to-Consumer Genetic Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Direct-to-Consumer Genetic Testing Market, highlighting leading vendors and their innovative profiles. These include Ancestry.com LLC, Dante Labs Inc., EasyDNA, FamilyTreeDNA by Gene, Ltd., Genesis Healthcare Co., Helix OpCo, LLC, Karmagenes SA, Living DNA Ltd., Mapmygenome, Merck KGaA, MyHeritage Ltd., Positive Biosciences, Ltd., Shuwen Biotech Co. Ltd., Vitagene, Inc., and Xcode Life.

Market Segmentation & Coverage

This research report categorizes the Direct-to-Consumer Genetic Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Mitochondrial DNA Testing, Single Nucleotide Polymorphism Testing, and Y Chromosome Testing.
  • Based on Channel, market is studied across Offline and Online.
  • Based on Function, market is studied across Ancestry & Ethnicity, Cancer Screening, Genetic Disease Carrier Status, New Baby Screening, Traits, and Wellness. The Cancer Screening is further studied across Hereditary Cancer and Sporadic Cancer. The Hereditary Cancer is further studied across Blood Cancer, Breast Cancer, and Ovarian Cancer.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Paradigm shift among consumers seeking greater control over their own healthcare
      • 5.1.1.2. Rising awareness about genome testing and risk of genetic diseases
      • 5.1.1.3. High aging population coupled with growing prevalence of chronic disorders
      • 5.1.1.4. Increased inquisitiveness about the assessment of lineage and ancestry
    • 5.1.2. Restraints
      • 5.1.2.1. Related scientific, technical, and clinical issues
      • 5.1.2.2. First amendment issues of honesty, fidelity to facts, and truth-in-advertising
    • 5.1.3. Opportunities
      • 5.1.3.1. Next-generation sequencing and bio-chip for present and future genetic diagnosis
      • 5.1.3.2. Development of online applications to serve customer needs
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity of test result interpretation
      • 5.1.4.2. Lack of adequate physician knowledge about genetics
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Direct-to-Consumer Genetic Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Mitochondrial DNA Testing
  • 6.3. Single Nucleotide Polymorphism Testing
  • 6.4. Y Chromosome Testing

7. Direct-to-Consumer Genetic Testing Market, by Channel

  • 7.1. Introduction
  • 7.2. Offline
  • 7.3. Online

8. Direct-to-Consumer Genetic Testing Market, by Function

  • 8.1. Introduction
  • 8.2. Ancestry & Ethnicity
  • 8.3. Cancer Screening
    • 8.3.1. Hereditary Cancer
      • 8.3.1.1. Blood Cancer
      • 8.3.1.2. Breast Cancer
      • 8.3.1.3. Ovarian Cancer
    • 8.3.2. Sporadic Cancer
  • 8.4. Genetic Disease Carrier Status
  • 8.5. New Baby Screening
  • 8.6. Traits
  • 8.7. Wellness

9. Americas Direct-to-Consumer Genetic Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Direct-to-Consumer Genetic Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Direct-to-Consumer Genetic Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ancestry.com LLC
  • 2. Dante Labs Inc.
  • 3. EasyDNA
  • 4. FamilyTreeDNA by Gene, Ltd.
  • 5. Genesis Healthcare Co.
  • 6. Helix OpCo, LLC
  • 7. Karmagenes SA
  • 8. Living DNA Ltd.
  • 9. Mapmygenome
  • 10. Merck KGaA
  • 11. MyHeritage Ltd.
  • 12. Positive Biosciences, Ltd.
  • 13. Shuwen Biotech Co. Ltd.
  • 14. Vitagene, Inc.
  • 15. Xcode Life

LIST OF FIGURES

  • FIGURE 1. DIRECT-TO-CONSUMER GENETIC TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DIRECT-TO-CONSUMER GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIRECT-TO-CONSUMER GENETIC TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MITOCHONDRIAL DNA TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SINGLE NUCLEOTIDE POLYMORPHISM TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY Y CHROMOSOME TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY & ETHNICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BLOOD CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SPORADIC CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GENETIC DISEASE CARRIER STATUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEW BABY SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 237. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. DIRECT-TO-CONSUMER GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023